Corvex (NASDAQ:MOVE) Upgraded to “Strong-Buy” at Chardan Capital

Corvex (NASDAQ:MOVEGet Free Report) was upgraded by Chardan Capital to a “strong-buy” rating in a research note issued on Wednesday, Zacks reports.

Several other research firms have also recently commented on MOVE. Wall Street Zen upgraded shares of Corvex from a “sell” rating to a “hold” rating in a research note on Sunday, May 24th. Weiss Ratings raised shares of Corvex from a “sell (d-)” rating to a “sell (d)” rating in a report on Thursday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Corvex has a consensus rating of “Moderate Buy” and an average price target of $18.75.

Get Our Latest Analysis on Corvex

Corvex Trading Up 2.0%

Shares of MOVE stock opened at $10.92 on Wednesday. The company has a market capitalization of $344.53 million, a P/E ratio of -0.58 and a beta of 0.90. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 4.28. The business’s 50 day moving average is $12.20 and its two-hundred day moving average is $15.32. Corvex has a twelve month low of $3.44 and a twelve month high of $26.72.

Corvex (NASDAQ:MOVEGet Free Report) last issued its quarterly earnings results on Friday, August 14th. The AI infrastructure company reported ($5.12) earnings per share for the quarter, missing the consensus estimate of ($3.17) by ($1.95). The company had revenue of $3.80 million during the quarter, compared to analysts’ expectations of $6.71 million.

About Corvex

(Get Free Report)

Movano Inc engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Featured Stories

Receive News & Ratings for Corvex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corvex and related companies with MarketBeat.com's FREE daily email newsletter.